|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
GUAR GUM WHEN COMCOMITANTLY ADMINISTERED WITH OTHER DRUGS, MAY RETARD THEIR ABSORPTION
|
BETABLOCKERS CAN BOTH INCREASE HYPOGLYCEMIA & MASK THE TYPICAL SYMPATHETIC HYPOGLYCEMIC WARNING SIGNS
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
OESTROGENS REDUCE THE HYPOGLYCEMIC EFFECTS OF ANTIDIABETICS
|
ALBENDAZOLE ACTION IS POTENTIATED BY THE DRUG
|
OCTREOTIDE ABSORPTION IS REDUCED BY THE DRUG
|
OCTREOTIDE ABSORPTION IS REDUCED BY THE DRUG
|
PROGESTERONES TEND TO PRODUCE HYPERGLYCEMIA AND MAY LEAD TO LOSS OF GLYCEMIC CONTROL
|